• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植患者的重症监护管理

Intensive care management of liver transplanted patients.

作者信息

Feltracco Paolo, Barbieri Stefania, Galligioni Helmut, Michieletto Elisa, Carollo Cristiana, Ori Carlo

机构信息

Paolo Feltracco, Stefania Barbieri, Helmut Galligioni, Elisa Michieletto, Cristiana Carollo, Carlo Ori, Department of Pharmacology and Anesthesiology, University Hospital of Padova, Padova 35100, Italy.

出版信息

World J Hepatol. 2011 Mar 27;3(3):61-71. doi: 10.4254/wjh.v3.i3.61.

DOI:10.4254/wjh.v3.i3.61
PMID:21487537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3074087/
Abstract

Advances in pre-transplant treatment of cirrhosis-related organ dysfunction, intraoperative patient management, and improvements in the treatment of rejection and infections have made human liver transplantation an effective and valuable option for patients with end stage liver disease. However, many important factors, related both to an increasing "marginality" of the implanted graft and unexpected perioperative complications still make immediate post-operative care challenging and the early outcome unpredictable. In recent years sicker patients with multiple comorbidities and organ dysfunction have been undergoing Liver transplantation; appropriate critical care management is required to support prompt graft recovery and prevent systemic complications. Early post-operative management is highly demanding as significant changes may occur in both the allograft and the "distant" organs. A functioning transplanted liver is almost always associated with organ system recovery, resulting in a new life for the patient. However, in the unfortunate event of graft dysfunction, the unavoidable development of multi-organ failure will require an enhanced level of critical care support and a prolonged ICU stay. Strict monitoring and sustainment of cardiorespiratory function, frequent assessment of graft performance, timely recognition of unexpected complications and the institution of prophylactic measures to prevent extrahepatic organ system dysfunction are mandatory in the immediate post-operative period. A reduced rate of complications and satisfactory outcomes have been obtained from multidisciplinary, collaborative efforts, skillful vigilance, and a thorough knowledge of pathophysiologic characteristics of the transplanted liver.

摘要

肝硬化相关器官功能障碍的移植前治疗进展、术中患者管理以及排斥反应和感染治疗的改善,使人类肝移植成为终末期肝病患者有效且有价值的选择。然而,许多重要因素,既与植入移植物“边缘性”增加有关,也与围手术期意外并发症有关,这仍使术后即刻护理具有挑战性,早期预后难以预测。近年来,患有多种合并症和器官功能障碍的病情较重的患者一直在接受肝移植;需要适当的重症监护管理来支持移植物迅速恢复并预防全身并发症。术后早期管理要求很高,因为同种异体移植物和“远处”器官都可能发生重大变化。一个功能正常的移植肝脏几乎总是与器官系统恢复相关,从而为患者带来新的生活。然而,在移植物功能障碍这一不幸事件中,多器官功能衰竭的不可避免发展将需要更高水平的重症监护支持和更长时间的重症监护病房住院时间。在术后即刻,必须严格监测和维持心肺功能,频繁评估移植物功能,及时识别意外并发症并采取预防措施以防止肝外器官系统功能障碍。通过多学科协作努力、熟练的警惕性以及对移植肝脏病理生理特征的透彻了解,并发症发生率降低且取得了令人满意的结果。

相似文献

1
Intensive care management of liver transplanted patients.肝移植患者的重症监护管理
World J Hepatol. 2011 Mar 27;3(3):61-71. doi: 10.4254/wjh.v3.i3.61.
2
Intensive care unit outcomes following orthotopic liver transplantation: single-center experience and review of the literature.原位肝移植后的重症监护病房结局:单中心经验及文献综述
G Chir. 2019 Nov-Dec;40(6):463-480.
3
[Postoperative intensive care of biliary atresia patients treated with living donor liver transplantation].[活体供肝肝移植治疗胆道闭锁患者的术后重症监护]
Zhonghua Er Ke Za Zhi. 2011 Jan;49(1):21-6.
4
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.
5
Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.人类免疫缺陷病毒感染者的肾脏和肝脏器官移植:一项基于证据的分析。
Ont Health Technol Assess Ser. 2010;10(4):1-56. Epub 2010 Mar 1.
6
Predictive factors of short term outcome after liver transplantation: A review.肝移植术后短期预后的预测因素:综述
World J Gastroenterol. 2016 Jul 14;22(26):5936-49. doi: 10.3748/wjg.v22.i26.5936.
7
Intensive care management of paediatric organ donors and its effect on post-transplant organ function.小儿器官捐献者的重症监护管理及其对移植后器官功能的影响。
Intensive Care Med. 1996 Dec;22(12):1424-32. doi: 10.1007/BF01709564.
8
Surgical intensive care - current and future challenges?外科重症监护——当前及未来的挑战?
Qatar Med J. 2020 Jan 13;2019(2):3. doi: 10.5339/qmj.2019.qccc.3. eCollection 2019.
9
Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3.肝移植治疗失代偿期肝硬化患者:急性慢加急性肝衰竭 3 级的多中心研究
J Hepatol. 2017 Oct;67(4):708-715. doi: 10.1016/j.jhep.2017.06.009. Epub 2017 Jun 21.
10
The use of contaminated donor organs in transplantation.移植中使用受污染的供体器官。
Clin Transplant. 2000 Aug;14(4 Pt 2):397-400. doi: 10.1034/j.1399-0012.2000.14040702.x.

引用本文的文献

1
Postoperative fluid balance and outcomes in pediatric living-donor liver transplant recipients: a retrospective cohort study.小儿活体肝移植受者术后的液体平衡与结局:一项回顾性队列研究
J Anesth. 2025 May 24. doi: 10.1007/s00540-025-03515-9.
2
High low mean arterial pressure target in liver transplant patients. An open, controlled, single-center, randomized clinical trial - Protocol and methods (LIVER-PAM).肝移植患者的高或低平均动脉压目标:一项开放、对照、单中心、随机临床试验——方案和方法(LIVER-PAM)。
Crit Care Sci. 2023 Mar 1;35(1):11-18. doi: 10.5935/2965-2774.20230336-en.
3
Association between hospital acquired disability and post-discharge mortality in patients after living donor liver transplantation.肝移植术后患者获得性残疾与出院后死亡率的相关性。
BMC Surg. 2022 Dec 29;22(1):445. doi: 10.1186/s12893-022-01896-2.
4
Impact of COVID-19 pandemic on liver, liver diseases, and liver transplantation programs in intensive care units.2019年冠状病毒病大流行对重症监护病房的肝脏、肝脏疾病及肝移植项目的影响
World J Hepatol. 2021 Oct 27;13(10):1215-1233. doi: 10.4254/wjh.v13.i10.1215.
5
Comparative study of the effect of neuromuscular electrical stimulation and oral administration of branched-chain amino acid on preventing sarcopenia in patients after living-donor liver transplantation: study protocol for an open-label randomized controlled trial.神经肌肉电刺激和口服支链氨基酸预防活体肝移植后患者肌少症的效果比较研究:一项开放标签随机对照试验的研究方案。
Trials. 2021 Feb 12;22(1):137. doi: 10.1186/s13063-021-05086-y.
6
Donor-specific cell-free DNA as a biomarker in liver transplantation: A review.供体特异性游离DNA作为肝移植生物标志物的综述
World J Transplant. 2020 Nov 28;10(11):307-319. doi: 10.5500/wjt.v10.i11.307.
7
Thirty-day readmission rates, trends and its impact on liver transplantation recipients: a national analysis.30 天再入院率、趋势及其对肝移植受者的影响:一项全国性分析。
Sci Rep. 2020 Nov 6;10(1):19254. doi: 10.1038/s41598-020-76396-5.
8
Liver transplantation in the era of COVID-19.新冠疫情时代的肝移植
Arab J Gastroenterol. 2020 Jun;21(2):69-75. doi: 10.1016/j.ajg.2020.04.019. Epub 2020 May 12.
9
Critical Care of the Liver Transplant Recipient.肝移植受者的重症监护
Curr Anesthesiol Rep. 2015;5(4):419-428. doi: 10.1007/s40140-015-0133-6. Epub 2015 Dec 1.
10
Liver function after transplantation in the assessment of the coagulation system and the concept of antithrombotic therapy.移植后肝功能在凝血系统评估及抗血栓治疗概念中的作用
Prz Gastroenterol. 2020;15(1):48-54. doi: 10.5114/pg.2020.93631. Epub 2020 Mar 19.

本文引用的文献

1
Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial.血栓弹力图引导下的输血减少原位肝移植术中输血:随机临床试验
Transplant Proc. 2010 Sep;42(7):2590-3. doi: 10.1016/j.transproceed.2010.05.144.
2
Recipient-based approach to tailoring immunosuppression in liver transplantation.肝移植中基于受者的免疫抑制调整方法。
Transplant Proc. 2010 Jun;42(5):1731-7. doi: 10.1016/j.transproceed.2010.02.076.
3
Central nervous system infectious complications early after liver transplantation.肝移植术后早期的中枢神经系统感染并发症
Transplant Proc. 2010 May;42(4):1216-22. doi: 10.1016/j.transproceed.2010.03.108.
4
How far can we go with positive end-expiratory pressure (PEEP) in liver transplant patients?肝移植患者的呼气末正压(PEEP)可以用多高?
J Clin Anesth. 2010 Mar;22(2):104-9. doi: 10.1016/j.jclinane.2009.03.015.
5
Improvement of renal function after conversion to mycophenolate mofetil combined with low-level calcineurin inhibitor in liver transplant recipients with chronic renal dysfunction.在慢性肾功能不全的肝移植受者中,转换为霉酚酸酯联合低剂量钙调神经磷酸酶抑制剂后肾功能的改善。
Transplant Proc. 2010 Mar;42(2):656-9. doi: 10.1016/j.transproceed.2010.02.006.
6
Indications for and survival after liver retransplantation.肝脏再次移植的适应证及术后生存率。
Transplant Proc. 2010 Mar;42(2):637-40. doi: 10.1016/j.transproceed.2010.02.017.
7
Biliary complications following deceased and living donor liver transplantation: a review.死体供肝和活体供肝肝移植后的胆道并发症:综述
Transplant Proc. 2010 Mar;42(2):517-20. doi: 10.1016/j.transproceed.2010.01.017.
8
Neurocognitive-neurological complications of liver transplantation: a review.肝移植的神经认知-神经并发症:综述。
Metab Brain Dis. 2010 Mar;25(1):115-24. doi: 10.1007/s11011-010-9183-0. Epub 2010 Mar 5.
9
Platelet transfusion can be related to liver regeneration after living donor liver transplantation.血小板输注可能与活体供肝移植后肝脏再生有关。
World J Surg. 2010 May;34(5):1052-8. doi: 10.1007/s00268-010-0464-x.
10
Critical care issues in adult liver transplantation.成人肝移植中的重症监护问题。
Indian J Crit Care Med. 2009 Jul-Sep;13(3):113-9. doi: 10.4103/0972-5229.58535.